+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Patient-centric Healthcare App Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)

  • PDF Icon


  • 173 Pages
  • August 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 5176587
UP TO OFF until Dec 31st 2023
Global patient-centric healthcare app (PCHA) market is anticipated to register a CAGR of nearly 38.99% during the forecast period.

The COVID-19 pandemic had an impact on the healthcare industry. The outbreak of COVID-19 led to disruption, challenges, limitations, and changes in every industry sector. The pandemic also impacted the studied market. The outbreak of COVID-19 showed a positive impact on the market, as lockdowns led to the lower availability of doctors in clinical settings.

Thus, patients were more inclined to use apps to manage their chronic conditions, such as diabetes, hypertension, and other chronic diseases. Moreover, there have been a large number of patient care apps launched for COVID-19 management. Nationwide lockdowns resulted in providing healthcare services by the hospitals and clinics, which led to the rise in the use of patient-centric healthcare app that aims toward the management of diseases.

For instance, according to a research study by Haridimos Kondylakis et al., published in the Journal of Medical Internet Research in December 2020, mobile apps were considered to be a valuable tool for health professionals, citizens, and decision-makers in facing critical challenges imposed by the pandemic such as reducing the burden on hospitals, tracking the symptoms and mental health of individuals, providing access to credible information, and discovering new predictors, leading to the high adoption of mobile health apps across the industry both from providers and consumers.

The major factors driving the market growth include the increased incidence of chronic disorders, such as cancers, diabetes, and rheumatoid arthritis, especially in the geriatric population. Treating chronic diseases requires continuous monitoring and evaluation of physiological changes for proper diagnosis and medication.

For instance, as per the IDF Diabetes Atlas Tenth edition 2021, in 2021, about 537 million adults were living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The increasing number of diabetes patients drives them to demand more monitoring apps and drives the market

According to World Health Organization (WHO) data published in October 2021, between 2015 and 2050, the proportion of the global population over 60 years will nearly double from 12% to 22% in 2050, and 80% of older people will be living in low- and middle-income countries. All countries face major challenges in ensuring their health and social systems are ready to make the most of this demographic shift. Thus, healthcare apps come in the role of monitoring vital parameters. This is expected to drive the market. Thus, the growing elderly population, rise in government initiatives to maintain electronic health record systems, and increased demand for technology-based treatment to avoid medication errors are likely to drive the patient-centric healthcare app (PCHA) market over the forecast period.

Key Market Trends

The Phone-based Apps Sub-segment is Expected to Hold Significant Market Share in the Patient-centric Healthcare App Market

The phone-based apps are expected to account for the largest revenue share in the overall patient-centric healthcare app market over the forecast period.

During the COVID-19 pandemic 2020, the maintenance of healthcare, well-being, and the social connection was crucial for the elderly population. Many mobile health apps were launched after countries relaxed their telehealth regulations to combat the COVID-19 pandemic. Mobile health apps help patients with their health conditions, and physicians deliver the services on their premises. According to the research study published in June 2022 by Dina M. El-Sherif& Mohamed Abouzid, mobile applications played a crucial role during the COVID-19 pandemic in management and patients other than COVID-19. Additionally, in January 2021, in India, Dell Technologies, in collaboration with the Ministry of Health and Family Welfare and Tata Trusts, developed a mobile application to manage non-communicable diseases at the government primary health centers (PHCs) across the country.

With the growing penetration of smartphone users globally and increasing demand for telehealth and mobile health services, the phone-based health application segment is expected to grow over the forecast period as companies offering telehealth services launch their applications with all the benefits.

Other advantages of phone-based health applications include an interactive and user-friendly interface, integrated solutions from consultation to payment, regular notification to keep the user updated, and depending upon the provider and function, phone-based healthcare applications can also be used without the internet. All these factors are collectively expected to boost growth in the studied segment over the forecast period.

North America Dominates the Market and Expected to do the Same in the Forecast Period.

North America is expected to dominate the overall patient-centric healthcare app (PCHA) market throughout the forecast period. The dominance is due to the region's huge target population base with chronic diseases, such as coronary heart diseases, atrial fibrillation, stroke, hypertension, and diabetes.

As per the American College of Cardiology Foundation 2021, deaths from hypertensive diseases and ischemic heart disease in the United States increased during the COVID-19 pandemic in 2020, leading to the increasing use of patient-centric health care apps during the pandemic in the United States in the management of the disease.

The rising geriatric population and the country's high burden of chronic diseases are expected to boost market growth. For instance, Heart disease is the main cause of death in the United States, according to the Centers for Disease Control and Prevention (CDC) September 2020. Around 805,000 Americans experience a heart attack each year. As the number of deaths due to heart diseases is increasing, there is a continuous need for the proper monitoring of cardiac diseases, and patient-centric healthcare apps fulfill the unmet needs; hence it is expected to show growth over the forecast period. Additionally, According to the American Diabetes Federation 2019 report, an estimated 463 million adults live with diabetes worldwide, which is estimated to reach 700 million by 2045.

Furthermore, a rise in healthcare expenditure, health awareness, and a shift from clinical-centric treatment to patient-centric care boost the market in the region. The growing adoption of technology by key healthcare providers in the region is expected to contribute to a significant global market share throughout the forecast period.

Competitive Landscape

The patient-centric healthcare app market is moderately competitive. Some companies are expanding their market position while others are adopting various strategies, such as mergers and acquisitions, introducing new products, and upgrading technologies, to maintain their market position. Some market players are Koninklijke Philips N V, Merck & Co. Inc., Hill-Rom Holdings Inc., Bayer AG, and Siemens Healthineers AG.

Additional benefits of purchasing this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1.1 Study Assumptions
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Diseases and Rising Geriatric Population
4.2.2 Enhanced Access and Flexibility with Novel Technologies
4.3 Market Restraints
4.3.1 The High Cost of Development
4.3.2 Reluctance by Regular Healthcare Providers
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Mode of Operation
5.1.1 Phone-based
5.1.2 Web-based
5.1.3 Hybrid Patient-centric Apps
5.2 By Application
5.2.1 Wellness Management
5.2.2 Disease And Treatment Management
5.2.3 Other Applications
5.3 By Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 Assurecare LLC (IPatient Care)
6.1.3 Merck & Co. Inc.
6.1.4 MobileSmith Inc.
6.1.5 Koninklijke Philips NV
6.1.6 Pfizer Inc.
6.1.7 Siemens Healthineers AG
6.1.8 Novartis AG
6.1.9 Bayer AG
6.1.10 Baxter International Inc. (hillrom Services, Inc.)
6.1.11 athenahealth Inc.
6.1.12 Allscripts Healthcare Solutions Inc.
6.1.13 International Business Machines Corporation (IBM)
6.1.14 Mfine Pvt. Ltd
6.1.15 Oracle (cerner Corporation)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Boston Scientific Corporation
  • iPatientCare Pvt Ltd
  • Merck & Co. Inc.
  • MobileSmith Inc.
  • Koninklijke Philips NV
  • Pfizer Inc
  • Siemens Healthineers AG
  • Novartis AG
  • Bayer AG
  • Baxter International Inc. (hillrom Services, Inc.)
  • athenahealth Inc.
  • Allscripts Healthcare Solutions Inc.
  • International Business Machines Corporation (IBM)
  • Mfine Pvt Ltd
  • Oracle (cerner Corporation)